Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
about
Combination therapies for combating antimicrobial resistanceβ-Lactamase Inhibition by 7-Alkylidenecephalosporin Sulfones: Allylic Transposition and Formation of an Unprecedented Stabilized Acyl-EnzymeInsight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics studyEffect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.The neglected intrinsic resistome of bacterial pathogens.Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophiliaPiperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.Inhibition of flucloxacillin tubular renal secretion by piperacillinAntibiotics from microbes: converging to kill.Carbohydrate-Based Host-Guest Complexation of Hydrophobic Antibiotics for the Enhancement of Antibacterial Activity.Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfoneComparative Evaluation of the in-vitro Activity of Six β-lactam/β-lactamase Inhibitor Combinations against Gram Negative Bacilli.Modulation of mecA Gene Expression by Essential Oil from Salvia sclarea and Synergism with Oxacillin in Methicillin Resistant Staphylococcus epidermidis Carrying Different Types of Staphylococcal Chromosomal Cassette mec.Randomized, multicentre, comparative clinical evaluation of cefuroxime-sulbactam versus amoxicillin-clavulanic acid therapy in the treatment of lower respiratory tract infections.Investigation for antimicrobial resistance-modulating activity of diethyl malate and 1-methyl malate against beta-lactamase class A from Bacillus licheniformis by molecular dynamics, in vitro and in vivo studies.High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase.Antimicrobial peptide isolated from Bacillus amyloliquefaciens K14 revitalizes its use in combinatorial drug therapy.A fluorescein-labeled AmpC β-lactamase allows rapid characterization of β-lactamase inhibitors by real-time fluorescence monitoring of the β-lactamase-inhibitor interactions.
P2860
Q27015710-2C72D4D8-D3BA-4CED-A675-71E204293930Q27680584-3C9DE806-6FC8-4B07-BC05-A40775A682D0Q28542531-2BA5E9F0-38B6-403D-A6D6-6696AE382A59Q30484874-190E2642-62E0-4AC9-AA24-48EDDBABD625Q33320525-462D5F6B-5877-42DB-9344-3F15B4DDD56BQ33883685-EDE04CF0-A339-4CDC-A070-A5B34BBB5C81Q36839703-06422CDA-7B4F-446C-A92D-432B1AA46C92Q37142437-DAFB3D57-6372-4E46-BEFC-63F906E69444Q37583238-201CAAA7-084E-4FBE-ABFC-6B896DDED64DQ40102211-43F832C2-43EA-4482-8381-AA5EC109652AQ41327338-13EE8ECD-98B3-40B7-8A21-D7F0245A21C8Q41437396-0703D6D1-8EE6-44D2-AD81-75B7E9EA47DCQ41789307-A26009D2-F9EB-43BE-8E17-1DE85AB889CAQ44682932-EF9E3046-3C70-4344-A309-727596C22D1FQ46489062-17223484-A3BD-472C-8A36-63A25133CC46Q46628237-347FC38A-FB99-4B42-8DF2-58247A2D92C2Q51359936-EC543580-BE7B-4DCE-80A3-7EDF3ADA90B6Q53392951-FA4E1809-56EF-4CF5-BD9B-BA42D7F1C950
P2860
Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
@ast
Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
@en
type
label
Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
@ast
Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
@en
prefLabel
Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
@ast
Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
@en
P2093
P2860
P1433
P1476
Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
@en
P2093
Cyrus R Kumana
Kwok-Yung Yuen
Nelson Lee
P2860
P304
P356
10.2165/00003495-200363140-00006
P577
2003-01-01T00:00:00Z
P6179
1031886568